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Major, adverse cardiac events (death, myocardial 
infarction, bypass surgery and reintervention) 00 
cur in 4 to 7% of all patients undergoing coronary 
balloon angioplasty. Prospectively collected clink 
cal data, and angiographic quantitative and quali- 
tatiie lesion morphologic WWSWlWtamlp~ 
dural factors were examined to determine 
whether the occurrence of these events could be 
predicted. Of 1,442 patients undergoing balloon 
angmplasty for native primary coronary disease in 
2 European multicenter trials, 69 had major, ad- 
verse cardiac procedural or itiospital complica 
tions after 21 balloon inflation and were randomly 
matched with patients who completed an unconr 
plicated iuhospital course after successful angi* 
plasty. No quantitative angiographic variable was 
associated with maor adverse cardiac events in 
univariate and multivariate analyses. Univariate 
analysis showed that major adverse cardiac 
events were associated with the following pm 
cedural variables: (1) unstable angma (odds ratio 
[OR] 3.11; p ~0.0001), (2) type C lesion (OR 2.53; 
p <O&04), (3) lesion location at a bend ~46” (OR 
2.34; p <O&04), and (4) stenosis located in the 
middle segment of the artery dilated (OR 1.88; p 
~0.03); and with the following postprocedural vari- 
able: angiographically visible dissection (OR 6.39; 
p *0.0001). Multivariate logistic analysis was pep 
formed to identify variables independently cork 
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lated with the occurrence of major adverse cardi- 
ac events. The preprocedural muttivariate model 
entered unstable angina (OR 3.77; p c0.0003), le 
sions located at a bend ~46” (OR 2.67; p cO.O006), 
and stenosis located in the middle portion of the 
artery dilated (OR 1.95; p ~0.04). lf all variables 
were included, then angiographically visible di+ 
section (OR 6.58; p c0.0001), unstable angina (OR 
3.46; p <O&02) and lesions located at a bend ~46” 
(OR 2.54; p ~0.006) were independent predictors 
of major adverse cardiac events. 
(AmJCardiol1993;72:14-20) 
I n the initial “National Heart, Lung, and Blood Insti- tute Percutaneous Transhnninal Coronary Angio- plasty Registry” publication, which described the 
immediate results of patients treated by balloon angio- 
plasty, major adverse cardiac events (i.e., death, myo- 
cat-dial infarction, coronary artery bypass grafting and 
repeat dilatation) were reported in 13.6% of patients.’ 
Because of improvement in operator experience, as well 
as radiographic equipment and balloon catheter design 
over the succeeding 5 years, this percentage decreased 
to 4 to 7%, despite xtension of the indications for coro- 
nary balloon angioplasty to include patients aged >70 
years, and those with multivessel disease or poor left 
ventricular function, prior bypass surgery, and more se- 
vere and complex lesions.26 Many clinical factors such 
as multivessel disease, female gender, unstable angina 
and multiple lesions, as well as qualitative angiograph- 
ic lesion morphology, including eccentricity, presence of 
calcium, lesion length, stenosis at a bend, stenosis at a 
branch point, presence of thrombus, and complex le- 
sions, have been suggested to be predictors of a major 
procedural or in-hospital cardiac event.3-9 Previous stud- 
ies used visual interpretation of the coronary angiogram, 
which is now known to be limited by considerable inter- 
and intraobserver variability.1a-12 Thus, quantitative 
coronary angiographic systems are now the “gold stan- 
dard” for objective geometric assessment of coronary 
narrowings, and for assessing the short- and long-term 
results of interventions.13$14 In addition to the actual de- 
gree of lumen narrowing, these quantitative coronary 
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systems can also provide detailed lesion morphologic 
characteristics uch as lesion length, atherosclerotic 
plaque area, lesion eccentricity and vessel curvature.13 
The present study investigated whether comprehensive 
evaluation of lesion morphology by quantitative coro- 
nary analysis, in addition to conventional qualitative as- 
sessment, and inclusion of baseline, clinical characteris- 
tics and procedural details, could identify patients at par- 
ticularly high risk for major procedural or in-hospital 
adverse cardiac events. The identilication of risk factors 
for the occurrence of these complications may be of 
considerable clinical value in deciding which patients or 
lesions would be suitable for an alternative treatment to 
balloon angioplasty. 
MEMODS 
In all, 1,442 patients were enrolled in 2 randomized, 
double-blind, placebo-controlled, restenosis prevention 
trials (CARPORT [n = 7071 and MERCATOR [n= 
7351) between December 1987 and June 1990. Neither 
trial (described in detail previously) found any clinical 
or angiographic benefit from the agent under investiga- 
tion.15,16 For the purpose of this ancillary study, the pa- 
tient cohort comprised those who had major procedural 
or in-hospital complications (as previously delined) after 
21 balloon inflation, regardless of the linal result of bal- 
loon angioplasty (group J; n = 69). Each patient in group 
I was randomly matched with 3 control patients by the 
date of angioplasty (to the nearest week in the same hos- 
pital) (group II, n = 207) to assess the predictability of 
major adverse cardiac events. In cases of multilesion di- 
latation, the most severe lesion was selected and used 
for comparison. Each available cineangiogram was sep- 
arately reviewed by 2 experienced interventionalists who 
were unaware of clinical or procedural information, or 
the outcome of intervention. 
Percdamous transluminal -w mi!Wasty 
procedure and angiographic analysis: At the begin- 
ning of the angioplasty procedure, all patients received a 
bolus of 10,000 IU of intravenous hepa& for prolonged 
procedures, an additional infusion of 5,000 IU/hour was 
commenced after 2 hours and continued until the end of 
the procedure. Aspirin was routinely administered to all 
patients in the MERCATOR trial and to those random- 
ized to placebo in the CARPORT trial.15J6 Use of a cal- 
cium antagonist was permitted for 24 to 48 hours after 
coronary balloon angioplasty. The choices of guiding 
catheter, guide wire, balloon type, inflation duration and 
pressure were made by the operator. Primary angioplas- 
ty success was delined at the time the guide catheter was 
removed as diameter stenosis ~50% by visual estimation, 
without the occurrence of a major adverse cardiac event. 
At least 2 angiographic projections (orthogonal if 
possible) were recorded in such a way that they were 
suitable for quantitative analysis by the Coronary Angi- 
ography Analysis System, which was validated and de- 
scribed in detail previously. l3 An example of an analy- 
sis is shown in Figure 1. 
The absolute stenosis and reference diameters were 
measured by the computer using the known contrast- 
empty, guiding catheter diameter as a scaling device. For 
that purpose, the catheter tips were retained for accurate 
measurement with a micrometer. To achieve maximal 
coronary vasodilation, either nitroglycerin (0.1 to 0.3 
mg) or isosorbide dir&rate (1 to 3 mg) was administered 
(intracoronary) to each affected coronary artery before 
angiography. All contour positions of the catheter and 
arterial segment were corrected for “pincushion distor- 
tion” introduced by the image intensifiers. Because the 
algorithm cannot measure total occlusions or lesions 
with Thrombolysis in Myocardial Infarction grade 1 per- 
fusion, a value of 0 mm was substituted for the mini- 
mal lumen diameter and 100% for percent diameter 
stenosis in such cases. 
Variables used in the analysis: BASELINE CLINICAL 
CHARACTERISTICS: The following patient-related variables 
were recorded in the patient files: age, gender, duration 
of angina, cholesterol level, previous myocardial infarc- 
tion current smoking, diabetes mellitus, extent of athero- 
sclerotic disease (single or multivessel), Canadian Car- 
diovascular Society angina classilication, and unstable 
angina (defined as pain at rest needing treatment with 
intravenous nitrates).17 
QUALITATIVE ANGIOGRAPHIC CHARACTERISTICS: The 
following qualitative lesion parameters were assessed: 
(1) vessel dilated (right, left anterior descending or left 
circumtlex); and (2) location of the stenosis in the ves- 
sel dilated, according to the numeric scheme proposed 
by Austen et all8 The following subdivisions were used 
for location of the stenosis: proximal corresponding with 
segments 1, 6 and 11; middle corresponding with seg- 
ments 2, 7, 13 and 15; distal corresponding with seg- 
FlGURE 1. Singleframe angiogram of proximal lsft ant&or 
descending (LAD) artery stenosis before dilatation in ri@t 
anterior oblique (30”) projection. Quantitative coronary anal- 
ysis was psrhwmed using Cardiivascular Angiography Analy- 
sis System. Arterial boundaries automatically detscted by 
system are shown on an@ogram, and diameter function 
curve derived fram these contours by interpolating is shown 
in middle part of f&We (upper curve). Lower hotimntal line 
(1.04 mm) is minimal lumen diameter. Outside vertical lines 
on glaph, and 2 vertical lines on amgmgram are lesion 
boundaftes (I&ion length 8.8 mm). innermost vertical line is 
position of minimal luminal diameter, and point where this 
line intersects diameter function curve (u-r horirontal 
fine) is considered mfbence diameter (3.25 mm; value not 
shown). Lesion length is automatically determined by curve 
turs analysis of detected vessel contours. 
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ments 8 to 10, 12 and 14; (3) type of lesion, delined by 
a modified Ambrose classilication, as follows: concen- 
tric, eccentric (a stenosis asymmetricahy positioned iu 
the vessel in any nonforeshortened augiographic projec- 
tion), tandem (2 discrete lesions in the same coronary 
segment separated by an apparently normal segment), 
multiple irregularities (22 serial diffuse irregularities in 
the same coronary segment), and totally occluded ves- 
se119; (4) a bend >45” was considered present if in any 
nonforeshortened projection, the balloon iu position to 
dilate was located in a portion of the vessel with a 245” 
angulation at end-diastolezO; (5) presence of a side 
branch in the lesion to be dilated; (6) presence of a side 
branch, separate from the actual esion but within the di- 
lated segment; (7) presence of intracoronary thrombus 
(a noncalcified filling defect within the lumen, sur- 
rounded by contrast material observed in multiple pro- 
jections or the persistence of contrast material within the 
lumen, or a visible embohzation of intraluminal material 
“downstream”)21; (8) presence of calcification (delined 
as lixed radiopaque densities in the area of the stenosis 
to be dilated); and (9) type of lesion (A, B or C) ac- 
cording to the American College of Cardiology/Ameri- 
can Heart Association Task Force.” 
QUANTITATIVELYANGIOGRAPHICCHARACTEF3STICS: The 
following quantitative measurements were obtain& mini- 
I I 
D REFERENCE DIAMETER (RD) 
I 
DETERMINED BY 
CURVATURE ANALYSIS 
DIAMETER FUNCTION 
FIGURE 2. Area between actual and reconstructed contours 
at obstruction site is measure of amount of atherosclerotic 
plaque. Length of obst~ctii is determined from diameter 
iimction on basis of automatically detected curvature analy- 
sis without interference by analyst. Symmetry is defined as 
coefficient of left- and right4and distance between mco~ 
strutted interpolated reference diameter and actual vessel 
contours at site of obstmction. in this equation, largest dis 
tame between actual and reconstructed contours becomes 
denominator, so that symmetrical lesion has value of 1, and 
a severely eccentric lesion has value of 0. To assess extent 
of coronary bendin& curvature value at obstnmtion site is 
computed as average value of ail individual curvature vaC 
ues along centedine of coronary segment, with curvature 
delinsd by rate of change of angle through which tangent to 
curve turns in moving along curve, and which for circle is 
equal to reciprocal of radius. Cuwature value and symmetry 
index are determined in projection in least fomshortened 
view (in which analyzed segment was longest between 2 de 
fined iandmarko and is expressed as continuous integer 
value, ranging from 0 for &might segment to 90 for seg- 
merit with 90” bend). MU) q minimal lumen diameter. 
mal lumen and interpolated reference diameters, diame- 
ter stenosis, lesion length and eccentricity, atherosclerotic 
plaque area and vessel curvature (Figure 2). 
PROCEDURAL FACTORS: Balloon-artery ratio was used 
to assess the suitability of the balloon size for the ves- 
sel segment, and was detiued as the ratio between the 
measured mean balloon size and the (interpolated) refer- 
ence diameter of the dilated segment. Angiographically 
visible dissections were delined according to modified 
National Heart, Lung, and Blood Institute criteria.22 
Reproducibilii of w assessment: Inter- 
observer variability of the 2 reviewers for qualitative le- 
sion assessment was examined in an arbitrarily selected 
number of lesions. The coronary angioplasty films of 
138 patients with 1.51 lesions (consecutive films reach- 
ing the core laboratory) were independently assessed for 
the diverse lesion morphologic haracteristics by each 
observer on 2 separate occasions, 3 months apart, with 
blinding for earlier assessment. Interobserver discordance 
was as follows: lesion eccentricity 21%; branch point lo- 
cation 29%; branch point location in dilated segment 
19%; bend point location 14%; presence of thrombus 
2%; presence of calcnication 10%; presence of dissection 
11%; and lesion type according to the American College 
of Cardiology/American Heart Association Task Force 
classilication 25%. 
statistical analysis: Analyses were performed to test 
the hypothesis that clinical, qualitative and quantitative 
lesion morphologic and procedural characteristics are 
important determinants of major adverse cardiac events. 
The risk of major cardiac adverse vents for each vari- 
able was expressed as au odds ratio: (probability of an 
event variable present/probability of no event variable 
present)/(probability of an event variable absent/probability 
of no event variable absent). 
Continuous variables were dichotomized by cut points 
derived by dividing the data into 2 groups, each con- 
taining approximately 50% of the population. This meth- 
od of subdivision has the advantage of being consistent 
for all variables and thus avoids any bias in selection of 
subgroups, which may be performed to emphasize apar- 
ticular point. An odds ratio (OR) of 1 for a particular 
variable suggests that its presence poses no additional 
risk for a major event. An OR > or <l suggests addi- 
tional or reduced risk, respectively. The 95% confidence 
intervals (CI) were calculated to describe the statistical 
certainty. If the CI included 1, no signiticant increased 
or reduced risk was deemed to be conferred by the vari- 
able. Multivariate analysis by multiple logistic regres- 
sion was performed to identify variables independently 
correlated with the occurrence of a major cardiac, pro- 
cedural or in-hospital adverse event, using only those 
variables ign&ant at the p ~0.1 level in the univariate 
analysis. All statistical analyses were performed with a 
commercial statistical package (BMDP Statistical Soft- 
ware Package 1990). 
RESULTS 
Of 1,442 patients recruited, balloon augioplasty was 
not performed iu 9 patients, because the lesion severity 
had changed or because of equipment failure. A further 
43 patients had (sub)totally occluded lesions that could 
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TABLE I Clinical Variables and the Risk for a Major Procedural or In-Hospital Adverse 
Cardiac Event 
Variable 
Patient Positive 
for Variable 
(event/total) 
Patient Negative 
for Variable 
(event/total) Odds Ratio (95% Cl) 
Myocardial infarction (history) 
Currently smoking 
Multivessel coronary narrowing 
Diabetes mellitus 
Age ( < 58 years) 
Duration of angina (> 142 days) 
Total cholesterol 
(~6.2 mmol/L; 1240 mg/dl) 
Canadian Cardiovascular Society 
class III or IV 
Men 
Unstable angina 
231107 
10145 
291117 
6125 
351136 
351137 
341129 
471169 
591221 
29169 
461169 
591231 
391146 
631251 
34/140 
31/135 
271132 
21/100 
10155 
391206 
0.73 (0.41 to 1.30) 
0.83 (0.39 to 1.79) 
0.89 (0.51 to 1.51) 
0.94 (0.36 to 2.46) 
1.08 (0.63 to 1.86) 
1.15 (0.66 to2.01) 
1.39 (0.78 to 2.48) 
1.45 (0.81 to2.61) 
1.64 (0.78 to 3.46) 
3.11 (1.72 to 5.61) 
Cl = confidence interval. 
TABLE II Lesion and Procedural Variables, and the Risk for a Major Procedural or 
In-Hospital Adverse Cardiac Event 
Variable 
Patient Positive Patient Negative 
for Variable for Variable 
(event/total) (event/total) Odds Ratio (95% Cl) 
Coronary artery dilated 
Right 
Left circumflex 
Left anterior descending 
Multiple site dilated 
Total occlusion 
Middle portion of vessel dilated 
Lesion morphology quantitatively derived 
before angioplasty 
Symmetry index (<0.34)* 
Minimal lumen diameter (> 0.98 mm) 
Diameter stenosis (< 62%) 
Length lesion (> 5.8 mm)* 
Vessel size (>2.53 mm) 
Atherosclerotic plaque (> 6.1 mmz)* 
Curvature index (> 19)* 
Lesion morphology; qualitative assessment 
Side branch in area of balloon 
Calcified lesion 
Side branch in stenosis 
Eccentric located stenosis 
Bend >45 
Type C lesion 
Procedural variables 
Balloon-artery ratio (> 1.02) 
Thrombus after dilatation 
lntimal tear or dissection 
15167 
17172 
371137 
12145 
8124 
361112 
30/121 
351139 
351136 
321127 
371140 
351127 
371128 
461186 
9133 
381144 
36/130 
31186 
19146 
171110 
417 
471111 
54/209 
521204 
32/139 
571231 
611252 
331164 
321131 
341137 
341140 
291125 
301134 
261125 
241124 
20180 
571233 
281122 
301136 
351180 
471220 
16/105 
621259 
19/155 
0.83 (0.43 to 1.59) 
0.90 (0.48 to 1.69) 
1.24 (0.72 to 2.14) 
1.11 (0.54to2.29) 
1.57 (0.64 to 3.84) 
1.88 (1.08 to 3.26) 
1.00 (0.56 to 1.77) 
1.02 (0.59 to 1.76) 
1.08 (0.63 to 1.86) 
1.12 (0.63 to 1.99) 
1.25 (0.72 to 2.17) 
1.45 (0.81 to 2.59) 
1.69 (0.94 to 3.05) 
0.99 (0.54 to 1.81) 
1.16 (0.51 to2.63) 
1.20 (0.69 to2.11) 
1.31 (0.75 to 2.28) 
2.34 (1.31 to4.15) 
2.53 (1.32 to 4.86) 
1.02 (0.48 to 2.14) 
4.31 (0.94 to 19.80) 
5.39 (2.90 to 10.00) 
*Although 276 lesions were analyzed in total, some could not be analyzed for certain variables. 
Cl = confidence interval. 
be neither reached nor crossed with the guide wire or 
balloon catheter. Thus, of 1,390 patients in whom bal- 
loon dilatation was actually performed, 69 had a major 
adverse cardiac event. Myocardial infarction occurred 
during or shortly after the procedure in 15 patients (1%) 
and during the hospital stay in an additional 22 (1.5%). 
Emergency coronary bypass graft surgery was necessary 
immediately after unsuccessful coronary balloon angio- 
plasty in 18 patients (1.3%), and the indication for 
surgery occurred after leaving the catheterization labo- 
ratory in a further 9 (1%). In 5 patients, a redilatation 
was performed uring the hospital stay. No patient died 
during the procedure or hospital stay. 
ClinicalckhambWcsas~dmajor* 
vm cardiac events (T&k I): Patients with unstable 
angina had more coronary events than did those without 
unstable angina (OR 3.11; p <O.OOOl; 95% CI 1.72 to 
5.61). Age, gender, duration of angina, serum cholester- 
ol, history of myocardial infarction, diabetes mellitus, 
multivessel disease and Canadian Cardiovascular Soci- 
ety angina class did not influence the occurrence of a 
major adverse cardiac event. 
A@ogr@ii lesion clmactdsticsaspreclktors 
of major adverse cardiac events (Table II): Location 
of the target lesion in the middle segment of the coro- 
nary artery dilated (OR 1.88; p ~0.03; 95% CI 1.08 to 
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3.26), lesions located at a bend ti.5” (OR 2.34; p 
<0.004; 95% CI 1.31 to 4.15), and type C lesions (OR 
2.53; p <0.004, 95% CI 1.32 to 4.86) were signiticant- 
ly associated with the occurrence of major adverse car- 
diac events; no other lesion morphologic haracteristic 
(whether assessed qualitatively or by quantitative analy- 
sis) predicted subsequent development of these events. 
Procedural predictors of mqjor adverse cardiac 
events: The presence of any type of angiographically 
visible dissection after the procedure was strongly asso- 
ciated with the subsequent occurrence of a major ad- 
verse cardiac event (OR 5.39; p -+XlO1; 95% CI 2.9 to 
10.0). Neither thrombus after dilatation nor balloon-ar- 
tery ratio was found to be predictive of major adverse 
cardiac events (Table II). 
l.o@stic regression analysis: In considering only 
baseline preprocedural factors, the model entered unsta- 
ble angina (OR 3.77; p <0.0003; 95% CI 1.89 to 7.48), 
lesions located at a bend >45” (OR 2.87; p <0.0005; 
95% CI 1.47 to 5.59), and stenosis located in the rnid- 
dle portion of the artery dilated (OR 1.95; p <0.04; 95% 
CI 1.01 to 2.74). When postprocedural variables were 
added, then unstable angina (OR 3.46; p <0.002; 95% 
CI 1.67 to 7.17), lesions located at a bend >45” (OR 
2.54; p ~0.006; 95% CI 1.26 to 5.13), and angiograph- 
ically visible dissection (OR 6.58; p <O.OOOl; 95% CI 
3.17 to 13.7) were independent predictors of major ad- 
verse cardiac events. 
DISCUSSION 
Despite the improvements in equipment and tech- 
nique that have made it possible to dilate >90 to 95% 
of coronary obstructions, the occurrence of procedural 
and in-hospital cardiac adverse events due to acute or 
subacute vessel closure continues to be largely unpredict- 
able. The reported hequency of so-called major cardiac 
adverse vents depends on the time window applied -
after the patient left the catheterization laboratory 1 to 
2%, or during and after the procedure 4 to 7%. In the 
present study, major adverse cardiac events were ob- 
served in 33 of 1,390 patients (2.4%) after 21 balloon 
inllation in the catheterization room and in a further 36 
(2.6%) during the hospitalization period. 
Risk factors of mqjor procedural and bhospital 
adverse cardiac events: In 1988, Ellis et al3 reported 
the results of 4,772 procedures performed between April 
1, 1982 and March 31, 1986, and found (using multi- 
variate analysis) 7 independent preprocedural factors re- 
lated to abrupt vessel closure: stenosis length 22 lumen 
diameters, female gender, stenosis at a bend point >45”, 
stenosis at a branch point, stenosis-associated hrombus 
(tilling defect or staining), other stenoses in the same 
vessel, and multivessel disease. They concluded that al- 
though an estimation of risk can be obtained before per- 
forming coronary balloon angioplasty, the most power- 
ful predictors of closure can only be assessed uring the 
procedure (postangioplasty percent diameter stenosis, in- 
timal tear or dissection, and prolonged postangioplasty 
use of heparin). The 1985-1986 National, Heart, Lung, 
and Blood Institute Percutaneous Transluminal Coronary 
Angioplasty Registry study analyzed 1,801 patients, and 
revealed that baseline factors inherently associated with 
increased occlusion rates included 3-vessel disease, 
high-risk status for surgery, and acute coronary insuffi- 
ciency, and lesion characteristics included severe steno- 
sis before coronary angioplasty diffuse disease or mul- 
tiple discrete lesions, thrombus and collateral flow from 
the lesion. De Feyter et al5 reported an acute coronary 
artery occlusion rate of 7.3% (total population 1,423), 
with unstable angina, multivessel disease and complex 
lesions as predictors for closure during or after the pro- 
cedure. 
In all the aforementioned studies that involved large 
groups of patients, lesion characteristics were visually 
assessed. No data are available on the predictability of 
major cardiac complications from quantitative coronary 
analysis, which has now emerged as the gold standard 
for assessment of long-term angiographic outcome of 
percutaneous transluminal coronary interventions.15J6 In 
addition to the “simple” quantitative parameters ofmin- 
imal lumen (obstruction) diameter, reference diameter 
(or vessel size) and percent diameter stenosis, quan- 
titative analysis computes length of the obstruction, area 
of atherosclerotic plaque, symmetry index of the steno- 
sis, and curvature of the vessel. In the present study, 
quantitative coronary analysis was combined with as- 
sessment of qualitative lesion morphology and clinical 
characteristics to determine whether this thorough, inte- 
grated approach could improve the prediction of major 
adverse cardiac events. 
The present results are in agreement with those of 
the earlier published studies showing that unstable angi- 
na, lesions located at a bend >45”, and angiographical- 
ly visible dissection after angioplasty were independent 
predictors of major procedural or in-hospital cardiac 
events. Lesion morphology as assessed by quantitative 
coronary analysis was not useful for the prediction of 
major adverse cardiac events. 
The well-described association of unstable angina 
with the occurrence of major adverse cardiac events was 
confumed in this study. Patients presenting with the clin- 
ical syndrome of unstable angina continue to provide the 
clinician with the diflicult task of selecting a suitable 
management strategy that usually needs to be applied on 
an urgent basis. The increasing use of intracoronary an- 
gioscopy may be helpful in substratifying these patients 
and therefore guiding therapeutic strategies that may im- 
prove short- and long-term outcome.23 
The location of the target lesion in a bend >45” was 
previously identitied by Ellis et al3 as a risk factor for 
acute vessel closure. Their explanation was that the bal- 
loon must necessarily tear an atherosclerotic fixed and 
rigid bend lesion, as it straightens and stretches the le- 
sion. Iu addition, the maximal stress is several times 
greater when there is a geometric discontinuity in the 
object to which the stress is applied. 
The association of midsegment balloon dilatation 
with a greater risk of major adverse cardiac events is not 
readily explicable and could simply be a chance finding. 
The most powerful predictor for major adverse car- 
diac events is the occurrence of an angiographically visi- 
ble dissection after angioplasty, which is not surprising 
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because all patients with procedural events had a dissec- 
tion with flow limitation on their postdilatation angio- 
gram, in agreement with previous reports.3,9 
Other investigators have found that thrombus on the 
predilatation angiogram was predictive for a major ad- 
verse cardiac event.” However, thrombus was seldom 
observed on the predilatation angiogram in the present 
study, although unstable angina, in which the presence 
of intracoronary thrombus is frequently observed,23,24 
was a risk factor for a major adverse cardiac event. In 
this study, patients with unstable angina were aggres- 
sively treated with intravenous heparin that may have ef- 
fectively dealt with intracoronary thrombus in some 
cases. Therefore, thrombus was not a remarkable angio- 
graphic feature in the study. 
In contrast with Black et aJ9 the balloon-artery ratio 
was not a factor for predicting major adverse cardiac 
events in the present study, although there was a differ- 
ence in definition. Because of such previously published 
findings, many investigators may have carefully ensured 
appropriate matching of balloon with artery size. 
From the literature, one would expect hat dilation of 
type C lesions would be a risk factor for a major ad- 
verse cardiac event, because it is associated with a ~60% 
acute success rate according to the American College of 
Cardiology/American Heart Association Task Force.22 
However, a recent study of 1,000 lesions by Myler et 
alz reported an angioplasty success rate of 90% for type 
C lesions, which was only slightly less than that for type 
A and B. In the present study, type C lesions were pre- 
dictive of major adverse cardiac events in univariate but 
not multivariate analysis. The relatively high discor- 
dance between observers uggests that the use of this 
subjective valuation should be cautiously interpreted.26 
Study limitations: The study cohort of this retro- 
spective analysis comprised patients recruited for 2 mul- 
ticenter, restenosis, pharmacologic prevention trials in 
Europe. Although in both trials, consecutive patients of 
the participating clinics were recruited, only 25% of 
those undergoing angioplasty were recruited, because 21 
specific exclusion criterion was found.15J6 
In the CARPORT trial, patients treated with the new 
thromboxane A2-receptor blockade did not receive as- 
pirin before or during the angioplasty procedure, but all 
others did; this may have influenced the incidence of 
major adverse cardiac events.27 
Although the Cardiovascular Angiography Analysis 
System has been validated and extensively described in 
the literature, validation studies of quantitatively derived, 
lesion morphologic haracteristics such as lesion length 
and eccentricity, and vessel curvature have not been per- 
formed.13 
Coronary angiography as a 2-dimensional silhouette 
of the vessel umen, is inherently limited for the assess- 
ment of atherosclerotic plaque morphology, as has been 
increasingly demonstrated by intravascular ultrasound 
techniques.28 Furthermore, the use of objective quanti- 
tative analysis does not provide insight to the prediction 
of major adverse cardiac events from angiographic mea- 
surements and lesion morphology. Newer and more so- 
phisticated quantitative analysis systems may be more 
helpful in this regard29; however, the combined use of 
intracoronary angioscopy and ultrasound is more likely 
to shed new light on the continued unpredictability of 
major adverse cardiac events after coronary interven- 
tions .
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